EUVIMEDEUVIMED entdecken
Editorial

Pharmacogenomics as a Design Input in Early‐Phase Drug Development

Amalia M Issa

Clinical Pharmacology in Drug Development · 2026-11 · 15 (11)

DOI: 10.1002/cpdd.70125 ↗

Kurz gefasst

Editorial in der Zeitschrift Clinical Pharmacology in Drug Development, online erschienen am 05.11.2026. Verfasst von Amalia M Issa. Beteiligte Einrichtung: Editor-in-Chief, Clinical Pharmacology in Drug Development, McGill University, Canada. Die Arbeit nennt 6 Literaturangaben. Gefördert von: No funding was obtained for this work..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Editor-in-Chief, Clinical Pharmacology in Drug Development, McGill University, Canada.

Förderung

  • No funding was obtained for this work.

Zitieren

APA

Issa, A. M. (2026). Pharmacogenomics as a Design Input in Early‐Phase Drug Development. Clinical Pharmacology in Drug Development, 15(11). https://doi.org/10.1002/cpdd.70125

Vancouver

Issa AM. Pharmacogenomics as a Design Input in Early‐Phase Drug Development. Clinical Pharmacology in Drug Development. 2026;15(11). doi:10.1002/cpdd.70125

BibTeX
@article{Issa2026,
  author = {Issa, Amalia M},
  title = {Pharmacogenomics as a Design Input in Early‐Phase Drug Development},
  journal = {Clinical Pharmacology in Drug Development},
  year = {2026},
  volume = {15},
  number = {11},
  doi = {10.1002/cpdd.70125}
}
Kostenlos starten →